head and neck cancer nanoparticle therapy (IMAGE)
Caption
Image shows cancer cell survival after treatment with an experimental nanoparticle-based therapy carrying a genetic molecule called miR-20a-5p. Researchers at Penn State conducted multiple laboratory tests to measure how many head and neck cancer cells remained alive after exposure to the nanoparticles. In one test in mice bearing tumors grown from human hypopharyngeal (or head and neck) cancer cells, a single dose of the therapy followed by light activation reduced the volume of illuminated tumors by about 95% within 48 hours.
Credit
Courtesy Daniel Hayes / Penn State
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.
License
CC BY-NC-ND